Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells

Biochem Biophys Res Commun. 2006 Jul 7;345(3):1014-21. doi: 10.1016/j.bbrc.2006.04.170. Epub 2006 May 6.


Proton pump inhibitors (PPIs) have been demonstrated to prevent gastric mucosal injury by mechanisms independent of acid inhibition. Here we demonstrate that both omeprazole and lansoprazole protect human gastric epithelial and endothelial cells against oxidative stress. This effect was abrogated in the presence of the heme oxygenase-1 (HO-1) inhibitor ZnBG. Exposure to either PPI resulted in a strong induction of HO-1 expression on mRNA and protein level, and led to an increased activity of this enzyme. Expression of cyclooxygenase isoforms 1 and 2 remained unaffected, and COX-inhibitors did not antagonize HO-1 induction by PPIs. Our results suggest that the antioxidant defense protein HO-1 is a target of PPIs in both endothelial and gastric epithelial cells. HO-1 induction might account for the gastroprotective effects of PPIs independently of acid inhibition, especially in NSAID gastropathy. Moreover, our findings provide additional perspectives for a possible but yet unexplored use of PPIs in vasoprotection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Animals
  • Cell Line, Tumor
  • Cyclooxygenase 1 / chemistry
  • Deuteroporphyrins / pharmacology
  • Endothelial Cells / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Gastric Acid / metabolism*
  • Gastric Mucosa / metabolism*
  • Heme Oxygenase-1 / antagonists & inhibitors
  • Heme Oxygenase-1 / biosynthesis*
  • Humans
  • Lansoprazole
  • Omeprazole / analogs & derivatives
  • Omeprazole / pharmacology
  • Oxidative Stress
  • Rats


  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Deuteroporphyrins
  • Enzyme Inhibitors
  • Lansoprazole
  • zinc deuteroporphyrin IX 2,4-bis(glycol)
  • Heme Oxygenase-1
  • Cyclooxygenase 1
  • Omeprazole